Patients News | pharmaphorum

News

Gates Foundation, Wellcome put $550m behind new TB jab

A potentially game-changing new vaccine for tuberculosis is set for a major clinical trials programme, thanks to $550 million in funding from philanthropic organisations t

News

England turns to digital health checks to cut GP pressure

The UK government has said it will start offering new digital health checks to older people in England next spring as an addition to in-person check-ups delivered mainly b

News

BMS’ Sotyktu cleared for NHS use in psoriasis

Just a few weeks after its approval in the UK, Bristol-Myers Squibb’s new oral psoriasis therapy Sotyktu has been recommended for routine NHS in England and Wales.

News

FDA approves first cell therapy for type 1 diabetes

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors.

News

AstraZeneca pledges $400m to fight deforestation

AstraZeneca has said it will plant 200 million trees across six continents by 2030 in an effort to fight escalating rates of deforestation around the globe that is contrib

News

DexCare raises $75m for digital patient booking system

DexCare has topped up its finances with a $75 million third round that will be used to fund the continued roll-out of its patient appointment booking platform.

Gates Foundation, Wellcome put $550m behind new TB jab

England turns to digital health checks to cut GP pressure

BMS’ Sotyktu cleared for NHS use in psoriasis

FDA approves first cell therapy for type 1 diabetes

AstraZeneca pledges $400m to fight deforestation

DexCare raises $75m for digital patient booking system

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks